Pediatric LeukemiaÃ¢ÂÂA ReviewSamantha C. Bernard, Ehab H. Abdelsamad, Paisley A. Johnson, Daniel L. Chapman and Madhukiran Parvathaneni*
Department of Biotechnology, Harrisburg University of Science and Technology, 326 Market St, Harrisburg, PA 17101, USA
- *Corresponding Author:
- Madhukiran Parvathaneni
Department of Biotechnology
Harrisburg University of Science and Technology
326 Market St, Harrisburg, PA 17101, USA
E-mail: [email protected]
Received date: April 14, 2017; Accepted date: May 03, 2017; Published date: May 09, 2017
Citation: Bernard SC, Abdelsamad EH, Johnson PA, Chapman DL, Parvathaneni M (2017) Pediatric Leukemia: Diagnosis to Treatment–A Review. J Cancer Clin Trials 2:130.
Copyright: © 2016 Mbamalu ON, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Leukemia is cancer of the blood and bone marrow, it is the most common cancer found in children and is found to be more than one fourth of pediatric cancers. It causes white blood cells to become abnormal and the body to become weak. This deficiency in the immune system reduces the body's ability to fight infection or simple airborne illnesses, causing extensive treatment of common pathogens and cancer treatment. The present review covers all topics, from diagnosis to treatment of pediatric leukemia, as well as the stages of growth and physiological changes throughout the process. As leukemia has a high mortality rate the chances of survival are low. Discussion on survival rate will be breached and thoroughly deciphered. We also included the topic of treatment and at which point patients may be considered terminal or advanced. By approaching these points, we better understand leukemia (from a scientific standpoint) and its properties throughout the course of treatment.